Nabriva Therapeutics (NBRVF) Q3 2017 Earnings

9NovExpected
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-5.6
-3.91
-2.23
-0.54

Details

Expected EPS
-0.59
Actual EPS
-0.79
Surprise EPS
-0.2
Surprise Percent
+33.9%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.79 per share for Q3 2017.

0 Comments

Share your thoughts